Early Alzheimer's detection study in Hong Kong communities
Part of Brain & nervous system, Mental health clinical trials.
This study aims to find early signs of Alzheimer's in the community through blood tests and assessments. It's for people who can think clearly and agree to participate without major health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and agree to join (with or without a family member or friend present)
- You are willing to give a blood sample and answer questions about your health and memory
- You are not currently in another clinical trial that might affect this study
- You do not have a serious, uncontrolled medical condition like a brain disorder, HIV, or certain autoimmune diseases
- You do not have active confusion or a treatable cause of memory problems (like vitamin deficiencies or thyroid issues)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a digital tool to help detect early signs of Alzheimer's disease in people aged 50 and older. It aims to find high-risk individuals who may benefit from early monitoring.
This research study tests new blood tests that may detect early signs of Alzheimer's disease in people who currently have normal thinking and memory. By participating, you help researchers understand who might be at risk and develop better ways to predict the disease early.
This trial looks for new ways to diagnose memory and thinking problems earlier. It involves a memory test, brain scan, and blood draw to find markers that could help identify cognitive disorders.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study follows people who are closely related to someone diagnosed with Alzheimer’s to see who develops memory or brain changes over time. It may help researchers understand risk and early signs, which could guide prevention in families like yours.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.